AIDS vaccines. Trials set in high-risk populations.
Cohen
J
J
D016915:AIDS Vaccines / Q000633:toxicity*; D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology / Q000517:prevention & control*; D035082:Federal Government; D015699:HIV Envelope Protein gp120 / Q000276:immunology; D006679:HIV Seropositivity; D006801:Humans; D008913:Minority Groups; D009316:National Institutes of Health (U.S.); D011994:Recombinant Proteins / Q000276:immunology; D012307:Risk Factors; D012749:Sexually Transmitted Diseases / Q000150:complications; D019966:Substance-Related Disorders; D014481:United States
D016915:AIDS Vaccines; D015699:HIV Envelope Protein gp120; D011994:Recombinant Proteins